Newsletters
Since I’ve noticed that many newsletters end up in the recipient’s SPAM folder, I’ve created this page as a precaution where all newsletters will be published.
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Viagra Might Help To Reduce Metastasis August 4, 2026
- Blocking BCL-XL Increases ADC Effectiveness August 4, 2026
- Pluvicto Moves Into First-Line Metastatic Prostate Cancer, Marking Shift Toward Earlier Radioligand Therapy August 4, 2026
- Newsletter 31/2026 August 2, 2026
Newsletter 8/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This time, I welcome you with the Milky Way! This week, we have some exciting updates on cutting-edge treatments in clinical and preclinical trials. I hope you find them as fascinating as I do! I bet you can guess […]
Newsletter 7/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi fellow warriors! This time, I welcome you with a haunting photo from the Venice Carnival, which has just begun. As many of you know, last week was ASCO GU 2025, and there’s a lot to cover. I’ve reviewed around 200 of the 400+ prostate cancer […]
Newsletter 6/2025
/in Newsletter/by MaxLAST WEEK TODAY! A summary of what was published on ProstateWarriors.com during the past week Hi, fellow fighters! This week, the updates are primarily in clinical research, we could call it the Nectin-4 week! As usual, we also have a podcast if you prefer to listen to the newsletter, you can find it HERE. Since I’ll need to […]